Thromboembolic disease in pregnancy

Obstetrics and Gynecology Clinics of North America

Volumn 31, Issue 2, 2004, Pages 319-344

  Doyle, Nora M ^a   Monga, Manju ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

BLEEDING; CLINICAL TRIAL; DYSFIBRINOGENEMIA; GENETIC ANALYSIS; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERSENSITIVITY; INCIDENCE; OSTEOPOROSIS; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; REVIEW; SIDE EFFECT; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOPHILIA;

ANTICOAGULANTS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PRENATAL CARE; THROMBOPHILIA;

EID: 2942538369     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2004.03.008     Document Type: Review

References (79)

1. Arkel Y.S., Ku D.H. Thrombophilia and pregnancy: review of the literature and some original data. Clin Appl Thromb Hemost. 7(4):2001;259-268
2. Zotz R.B., Gerhardt A., Scharf R.E. Inherited thrombophilia and gestational venous thromboembolism. Best Pract Res Clin Haematol. 16(2):2003;243-259
3. Greer I.A. Thrombosis in pregnancy: maternal and fetal issues. Lancet. 353:1999;1258-1265
4. Whitty J.E., Dombrowski M.P. Respiratory diseases in pregnancy. Gabbe S.G., Niebyl J.R., Simpson J.L. Obstetrics normal and problem pregnancies. 4th edition:2002;1046-1053 Churchill Livingstone, Philadelphia
5. Gates S., Brocklehurst P., Davis L.J. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev. (2):2002;CD001689
6. Creasy R.K., Resnik R. Maternal-fetal medicine. 4th edition:1999;821-831 W.B. Saunders, Philadelphia
7. Greer I.A. Hypercoagulable states and pregnancy. Curr Hematol Rep. 1:2002;56-62
8. Zotz R.B., Gerhardt A., Scharf R.E. Prediction, prevention, and treatment of venous thromboembolic disease in pregnancy. Semin Thromb Hemost. 29:2003;143-154
9. Toglia M.R., Nolan T.E. Venous thromboembolism during pregnancy: a current review of diagnosis and management. Obstet Gynecol Surv. 52:1997;60-72
10. Wouters M.G., Novakova I.R., Steegers E.A. Thrombophilia and the prevention of thromboembolic complications during pregnancy and the puerperium. Ned Tijdschr Geneeskd. 147:2003;1060-1066
11. Eldor A. Thrombophilia, thrombosis and pregnancy. Thromb Haemost. 86:2001;104-111
12. Greer I.A. Inherited thrombophilia and venous thromboembolism. Best Pract Res Clin Obstet Gynaecol. 17:2003;413-425
13. National Institutes of Health. Consensus Development Conference Prevention of venous thrombosis and pulmonary embolism. JAMA. 256:1986;744
14. Conrad J., Horellou M.H., Samama M.M. Inherited thrombophilia and gestational venous thromboembolism. Semin Thromb Hemost. 29:2003;131-141
15. Pabinger I., Grafenhofer H. Pregnancy-associated thrombosis. Wien Klin Wochenschr. 115:2003;482-484
16. Hervig T., Haram K., Sandset P.M. Deep vein thrombosis in pregnant women. Tidsskr Nor Laegeforen. 118:1998;4093-4097
17. Virchow R. Phlogose und thrombose in gefass-system. Virchow R. Gesamelte abhandlungen zur wissenschaflichen medecin. 1856;458 Von Medinger Sohn, Frankfurt (Germany). in Germany
18. Greer I.A. Thrombophilia: implications for pregnancy outcome. Thromb Res. 109:2003;73-81
19. Greer I.A. Haemostasis and thrombosis in pregnancy. Bloom A.L., Forbes C.D., Thomas D.P., Tuddenham E.G.D. Haemostasis and thrombosis. 1994;987-1015 Churchill Livingstone, Edinburgh (UK)
20. Sipes S.S.L., Weiner C.P. Venous thromboembolic disease in pregnancy. Semin Perinatol. 14:1990;103
21. Uszynski M., Abildgaard U. Separation and characterization of two fibrinolytic inhibitors from human placenta. Thromb Diath Haemorrh. 25:1971;580
22. Tait R.C., Walker I.D., Reitsma P.H., et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost. 73:1995;87-93
23. Ballegeer V., Mombaerts P., Declerck P.J., et al. Fibrinolytic response to venous occlusion and fibrin fragment D-dimer levels in normal and complicated pregnancy. Thromb Haemost. 38:1987;1030
24. Ginsberg J.S., Brill-Edwards P., Burrows R.F., et al. DVT during pregnancy: leg and trimester of presentation. Thromb Haemost. 67:1992;519-520
25. Kupferminc M.J., Eldor A., Steinman N., et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. 340:1999;9
26. Rai R.S., Regan L., Hadley E., et al. Second trimester pregnancy loss is associated with activated protein C resistance. Br J Haematol. 92:1996;489-490
27. Grandone E., Margaglione M., Colaizzo D., et al. Factor V Leiden is associated with repeated and recurrent explained fetal losses. Thromb Haemost. 77:1997;822-824
28. Brenner B., Mandel H., Lanir N., et al. Activated protein C resistance can be associated with recurrent fetal loss. Br J Haematol. 97:1997;551-554
29. Dizon-Townson D.S., Meline L., Nelson L.M., et al. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol. 177:1997;402-405
30. Rai R.S., Regan L., Chitolie A., et al. Placental thrombosis in second trimester miscarriage in association with activated protein C resistance. Br J Obstet Gynaecol. 103:1996;842-844
31. Preston F.E., Rosendaal F.R., Walker I.D., et al. Increased fetal loss in women with heritable thrombophilia. Lancet. 348:1996;913-916
32. Sanson B.J., Friederich P.W., Simioni P., et al. The risk of abortion and stillbirth in antithrombin, protein S and protein S deficient women. Thromb Haemost. 75:1996;387-388
33. Ogunyemi D., Cuellar F., Ku W., et al. Association between inherited thrombophilias, antiphospholipd antibodies, and lipoprotein a levels and venous thromboembolism in pregnancy. Am J Perinatol. 20:2003;17-23
34. Yilmazer M., Kurtay G., Sonmezer M., et al. Factor V Leiden and prothrombin 20210 G-A mutations in controls and in patients with thromboembolic events during pregnancy or the puerperium. Arch Gynecol Obstet. 268:2003;304-308
35. Bertina R.M. Factor V Leiden and other coagulation factor mutations affecting thrombotic risk. Clin Chem. 43:1997;1678
36. Rosenburg R.D. Actions and interaction of antithrombin III and heparin. N Engl J Med. 292:1975;146
37. McColl M., Ramsay J.E., Tait R.C., et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost. 78:1997;1183-1188
38. Lane D.A., Olds R.J., Boisclair M., et al. Antithrombin mutation database: first update. Thromb Haemost. 70:1993;361
39. Hellgren M., Tengborn L., Abildgaard U. Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombin. Gynecol Obstet Invest. 14:1982;127
40. Rutherford S.E., Phelan J.P. Thromboembolic disease in pregnancy. Clin Perinatol. 13:1988;719
41. Marlar R.A., Montgomery R.R., Broekmans A.W., et al. Diagnosis and treatment of homozygous protein C deficiency: Report of the Working Party on Homozygous Protein C Deficiency of the Subcommittee on Protein C and Protein S. International Committee on Thrombosis and Haemostasis. J Pediatr. 114:1989;528
42. Malar R.A., Montgomery R., Broekmans A.W. Diagnosis and treatment of homozygous protein C deficiency. J Pediatr. 114:1989;528
43. Dahlback B., Carlsson M., Svensson P.J. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C. Proc Natl Acad Sci U S A. 90:1993;1004-1008
44. Bertina R.M., Keolman B.P., Koster T., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 369:1994;64
45. Conrad J., Horellou M.H., van Dreden P., et al. Pregnancy and congenital deficiency in antithrombin III or protein C. Thromb Haemost. 58:1987;39
46. American College of Obstetricians and Gynecologists Thromboembolism in pregnancy. Clinical management guidelines for obstetrician-gynecologists. ACOG Pract Bull. 19:2000
47. Dizon-Townson D.S., Nelson L.M., Easton K., et al. The factor V Leiden mutation may predispose women to severe pre-eclampsia. Am J Obstet Gynecol. 175:1996;902-905
48. Hough R.E., Makris N., Preston F.R. Pregnancy in women with thrombophilia: incidence of thrombosis and pregnancy outcome [abstract]. Br J Haematol. 93(Suppl 2):1996;136
49. deStefano V., Leone G., Masterangelo S., et al. Thrombotic risk during pregnancy and puerperium in women with APC resistance: effective subcutaneous heparin prophylaxis in a pregnant patient. Thromb Haemost. 74:1995;793-794
50. Rosendaal F.R., Koster T., Vandenbroucke J.P., et al. High risk of thrombosis in patients homozygous for factor V Leiden (APC resistance). Blood. 85:1995;1505
51. Den Heijer M., Koster T., Blom H.J., et al. Hyperhomocysteinemia as a risk factor for deep vein thrombosis. N Engl J Med. 334:1998;759-762
52. 6 supplementation on women with hyperhomocysteinemia and a history of pre-eclampsia or fetal growth restriction. Am J Obstet Gynecol. 179:1998;136-139
53. Poort S.R., Rosendaal F.R., Reitsma P.H., et al. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 88:1996;3698
54. Gerhardt A., Scharf R.E., Beckmann M.W., et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med. 342:2000;374-380
55. Mammen E.F. Congenital coagulation disorders. Semin Thromb Hemost. 9:1983;1
56. Andres R.L., Miles A. Venous thromboembolism and pregnancy. Obstet Gynecol Clin. 28:2001;613-630
57. Bowles L., Cohen H. Inherited thrombophilias and anticoagulation in pregnancy. Best Pract Res Clin Obstet Gynaecol. 17(3):2003;471-489
58. Cunningham F.G., Gant N.F., Leveno K.J., et al. Williams obstetrics. 21st edition:2001;McGraw-Hill, Norwalk (CT)
59. Francalanci I., Comeglio P., Alessandrello L., et al. D-dimer concentrations during normal pregnancy as measured by ELISA. Thromb Res. 78:1995;399-405
60. Doyle N.M., Ramirez M., Mastrobattista J., et al. Diagnosis of pulmonary embolism: a cost-effective analysis. Am J Obstet Gynecol. 189:2003;S142
61. Malkamy H. Heparin therapy in post cesarean septic pelvic thrombophlebitis. Int J Gynecol Obstet. 17:1980;564
62. Bahson R.R., Wendel E.F., Vogelzang R.L. Renal vein thrombosis following puerperal ovarian vein thrombophlebitis. Am J Obstet Gynecol. 152:1985;290
63. Brown C.E., Stettler R.W., Twickler D., et al. Puerperal septic pelvic thrombophlebitis: incidence and response to heparin therapy. Am J Obstet Gynecol. 181:1999;143-148
64. Gibson P.S., Rosene-Montella K. Drugs in pregnancy. Anticoagulants. Best Pract Res Clin Obstet Gynaecol. 15:2001;847-861
65. The SMFM Practice Committee Enoxaparin sodium (lovenox) and pregnancy. Available at: http://www.smfm.org/index.cfm?zone. Accessed January 21, 2004
66. Blomback M., Bremme K., Hellgren M., et al. Thromboprophylaxis with low molecular mass heparin, fragmin (dalteparin), during pregnancy - a longitudinal safety study. Blood Coagul Fibrinolysis. 9:1998;1-9
67. Blomback M., Bremme K., Hellgren M., et al. A pharmacokinetic study of dalteparin (fragmin) during late pregnancy. Blood Coagul Fibrinolysis. 9:1998;343-350
68. Rey E., Rivard G.E. Adequacy of subcutaneous dalteparin doses during pregnancy [abstract]. Presented at the XVIIth Congress of the International Society of Thrombosis and Haemostasis. Washington, DC, August 14-20, 1999
69. Fejgin M.D., Lourwood D.L. Low molecular weight heparins and their use in obstetrics and gynecology. Obstet Gynecol Surv. 49:1994;424-431
70. Rey E., Rivard G.E. Prophylaxis and treatment of thromboembolic diseases during pregnancy with dalteparin. Int J Gynecol Obstet. 71:2000;19-24
71. Noble S., Peters D.H., Goa K.L. Enoxaparin: a reappraisal of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disease. Drugs. 49:1995;388-410
72. Lovenox. Physicians' desk reference. 52nd edition:1998;2369-2371 Medical Economics, Montvale (NJ)
73. Katz V.L. Thrombophilias in ob/gyn: part II: treatment strategies. Contemp Ob Gyn. November:2002;59-70
74. Wells P.S., Holbrook A.M., Crowther N.R., et al. Interactions of warfarin with drugs and food. Ann Intern Med. 121:1994;676-683
75. McPhedran P. Venous thromboembolism during pregnancy. Burrow G.N., Ferris T.F. Medical complications during pregnancy. 4th edition:1995;83-95 WB Saunders, Philadelphia
76. Hale T.W. Medications and mothers' milk. 10th edition:2002;Pharmasoft Publishing, Amarillo (TX)
77. Briggs G.G., Freeman R.K., Yaffe S.J. Drugs in pregnancy and lactation. 5th edition:1998;Williams and Wilkins, Baltimore (MD)
78. Food and Drug Administration Public Health Advisory Report Reports of epidural or spinal hematomas with the concurrent use of low molecular weight heparin and spinal/epidural anesthesia or spinal puncture. 1997;Food and Drug Administration, Rockville (MD)
79. Ramin S.M., Gambling D.R., Lucas M.J., et al. Randomized trial of epidural versus intravenous analgesia during labor. Obstet Gynecol. 86:1995;783-789